| Authors: |
Hicks LK; St Michael's Hospital & University of Toronto, Toronto, ON, Canada., Messersmith HJ; American Society of Clinical Oncology (ASCO), Alexandria, VA., Al Hadidi S; University of Texas Southwestern Medical Center, Dallas, TX., Banerjee R; Fred Hutchinson Cancer Center, Seattle, WA., Derman BA; University of Chicago, Chicago, IL., Kumar S; Mayo Clinic, Rochester, MN., Wildes TM; University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE., Bal S; University of Alabama at Birmingham, Birmingham, AL., Bhella S; Princess Margaret Cancer Centre, Toronto, ON, Canada., Chmielewski C; Health Tree Foundation, Trenton, NJ., Costello C; UC San Diego Moores Cancer Center, La Jolla, CA., Dabney R; Texas Oncology, Grapevine, TX., Hartley-Brown M; Dana Farber Cancer Institute, Boston, MA., Langerak A; Arizona Oncology, Prescott, AZ., Lipe B; James P. Wilmot Cancer Center, Rochester, NY., Martin T; University of California San Francisco, San Francisco, CA., McCurdy A; Ottawa Hospital, Ottawa, ON, Canada., Mian H; Juravinski Cancer Centre, Hamilton, ON, Canada., Riva E; Hospital de Clínicas, Montevideo, Uruguay., Seth R; Upstate Medical Center Syracuse University, Syracuse, NY., Subramanian L; Anchorage Oncology Centre, Anchorage, AK., Mikhael J; Translational Genomics Research Institute (City of Hope Cancer Center), Phoenix, AZ. |